Multicenter, Open, Non-randomized 6 Months Study to Evaluate Efficacy and Safety Insuman Basal, Insuman Comb 25, Insuman Rapid in Insulin-naive Patients With T2DM Who Received Baseline Education Course in the Diabetes School.

Trial Profile

Multicenter, Open, Non-randomized 6 Months Study to Evaluate Efficacy and Safety Insuman Basal, Insuman Comb 25, Insuman Rapid in Insulin-naive Patients With T2DM Who Received Baseline Education Course in the Diabetes School.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jul 2014

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SPIRIT
  • Sponsors Sanofi
  • Most Recent Events

    • 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Mar 2013 Planned number of patients changed from 550 to 558 as reported by ClinicalTrials.gov.
    • 28 Mar 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top